Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,000 | -14,000 | -36,000 | 61,000 | -129,000 |
| Depreciation Amortization | 28,000 | 19,000 | 11,000 | 5,000 | 15,000 |
| Income taxes - deferred | 7,000 | -30,000 | -24,000 | 3,000 | -65,000 |
| Accounts receivable | -1,000 | 3,000 | -6,000 | 4,000 | -33,000 |
| Other Working Capital | -46,000 | 40,000 | 78,000 | -113,000 | -294,000 |
| Other Operating Activity | 41,000 | 35,000 | 28,000 | 3,000 | 206,000 |
| Operating Cash Flow | $36,000 | $53,000 | $51,000 | $-37,000 | $-300,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,000 | -14,000 | -9,000 | -4,000 | -45,000 |
| PPE Investments | -29,000 | -13,000 | -6,000 | -2,000 | -8,000 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -129,000 |
| Sale Of Investment | 117,000 | 88,000 | 42,000 | 31,000 | 129,000 |
| Purchase Sale Intangibles | -2,000 | -1,000 | -1,000 | -1,000 | -45,000 |
| Other Investing Activity | -2,000 | 0 | -1,000 | 0 | -42,000 |
| Investing Cash Flow | $69,000 | $61,000 | $26,000 | $25,000 | $-95,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 332,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -240,000 | -2,000 | -1,000 | -1,000 | -12,000 |
| Common Stock Issued | 3,000 | 3,000 | 2,000 | 2,000 | 3,000 |
| Common Stock Repurchased | -173,000 | -123,000 | -71,000 | -36,000 | -33,000 |
| Other Financing Activity | -24,000 | -20,000 | -21,000 | -21,000 | -22,000 |
| Financing Cash Flow | $-102,000 | $-142,000 | $-91,000 | $-56,000 | $-64,000 |
| Exchange Rate Effect | N/A | -1,000 | N/A | N/A | 1,000 |
| Beginning Cash Position | 316,000 | 316,000 | 316,000 | 316,000 | 774,000 |
| End Cash Position | 319,000 | 288,000 | 302,000 | 248,000 | 316,000 |
| Net Cash Flow | $3,000 | $-28,000 | $-14,000 | $-68,000 | $-458,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,000 | 53,000 | 51,000 | -37,000 | -300,000 |
| Capital Expenditure | -29,000 | -13,000 | -6,000 | -2,000 | -8,000 |
| Free Cash Flow | 7,000 | 40,000 | 45,000 | -39,000 | -308,000 |